HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CPSC

This article was originally published in The Rose Sheet

Executive Summary

Commissioner Mary Sheila Gall asks her nomination to chair Consumer Products Safety Commission be officially withdrawn after it was rejected by Senate Commerce Committee Democrats in July. Decision not to push for vote on Senate floor was made because Gall "felt the [committee] vote was partisan political, and she didn't want to continue the fight," according to commissioner's office. Gall will continue as a commissioner of the agency until her term expires in 2005. Bush Administration's choice to head CPSC was rejected in split vote down party lines with democrats questioning Gall's industry-friendly voting record (1"The Rose Sheet" Aug. 6, In Brief). Administration will need new nominee; resignation of current Chair Ann Brown is effective Nov. 1 (2"The Rose Sheet" Aug. 13, In Brief)

You may also be interested in...



CPSC

Child-resistant packaging of baby oil, other mineral-oil containing products listed as one of several areas of action targeted for completion by end of Chairman Ann Brown's term in her Aug. 8 letter of resignation. Brown announces intention to step down from post effective Nov. 1, barring earlier nomination and confirmation of another chair. "Nobody would be more pleased than I would if President Bush uses this opportunity to appoint a new chairman who shares his philosophy, and also believes in the mission of this agency," Brown asserts. Bush Administration likely will abandon push to appoint Mary Sheila Gall chair and proffer new candidate when Congressional recess ends, according to Senate Commerce Committee staffer. Gall's nomination was rejected by Commerce Committee Aug. 2 in split vote down party lines (1"The Rose Sheet" Aug. 6, In Brief)

CPSC

Nomination of Mary Sheila Gall as chair of Consumer Products Safety Commission opposed by Senate Commerce Committee Democrats Aug. 2. Nomination was rejected in split vote down party lines; Democrats hold a 12-11 majority. During July 25 hearing, several majority members questioned Gall's commitment to consumer safety, suggesting her industry-friendly voting record goes against CPSC's mission. "Mary Gall did not lose today, bipartisanship lost today," Bush Administration Press Secretary Ari Fleischer said in an Aug. 2 statement. "Many of the same Senators who voted for Mary Gall when she was nominated by President Clinton just two years ago, voted against her today demonstrating the purely partisan nature of this vote." The Administration could still push for a vote on the Senate floor, although Senate Majority Leader Tom Daschle (S.D.) has said he will not allow such an action. Gall has served as one of three CPSC commissioners since December 1991

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009640

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel